HNRNPC and metastatic malignant neoplasm in the lymph nodes: Next, the m6A regulator HNRNPC was selected as the most influential predictor for NSCLC, and HNRNPC predicted poor prognosis and correlated with tumor invasion and lymph node metastasis.